OC-0486: Pravastatin reverses fibrosis in head and neck cancer patients: phase II clinical trial results

Radiotherapy and Oncology ◽

10.1016/s0167-8140(18)30796-5 ◽

2018 ◽

Vol 127 ◽

pp. S250

Author(s):

C. Bourgier ◽

S. Rivera ◽

M.C. Vozenin ◽

P. Boisselier ◽

D. Azria ◽

...

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Head And Neck ◽

Cancer Patients ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Clinical Trial ◽

Clinical Trial Results

Download Full-text

Phase II clinical trial of peptide vaccination for advanced head and neck cancer patients induced immune responses and prolonged OS

Annals of Oncology ◽

10.1093/annonc/mdx376.015 ◽

2017 ◽

Vol 28 ◽

pp. v409

Author(s):

Y. Yoshitake ◽

D. Fukuma ◽

M. Hirayama ◽

H. Nakayama ◽

H. Ogi ◽

...

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Immune Responses ◽

Head And Neck ◽

Cancer Patients ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Clinical Trial ◽

Advanced Head ◽

Peptide Vaccination

Download Full-text

Phase II clinical trial of multiple peptide vaccination for advanced head and neck cancer patients with induced immune responses and a prolonged OS.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.3094 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 3094-3094

Author(s):

Yoshihiro Yoshitake ◽

Daiki Fukuma ◽

Akira Yuno ◽

Masatoshi Hirayama ◽

Hideki Nakayama ◽

...

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Immune Responses ◽

Head And Neck ◽

Cancer Patients ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Clinical Trial ◽

Advanced Head ◽

Peptide Vaccination

Download Full-text

Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-14-0202 ◽

2014 ◽

Vol 21 (2) ◽

pp. 312-321 ◽

Author(s):

Yoshihiro Yoshitake ◽

Daiki Fukuma ◽

Akira Yuno ◽

Masatoshi Hirayama ◽

Hideki Nakayama ◽

...

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Immune Responses ◽

Head And Neck ◽

Cancer Patients ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Clinical Trial ◽

Advanced Head ◽

Peptide Vaccination

Download Full-text

Adding Hyperthermia To Salvage Concurrent Chemoradiotherapy For Previously Irradiated Unresectable Recurrent Head And Neck Cancer: A Phase II Clinical Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.262 ◽

2020 ◽

Vol 108 (3) ◽

pp. e790

Author(s):

K.L. Yang ◽

M.S. Chi ◽

H.L. Ko ◽

Y.Y. Huang ◽

R.H. Wu ◽

...

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Clinical Trial ◽

Download Full-text

Phase II clinical trial of suberoylanilide hydroxamic acid (SAHA) in patients (pts) with recurrent and/or metastatic head and neck cancer(SCCHN)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.5578 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5578-5578

Author(s):

G. Blumenschein ◽

C. Lu ◽

M. Kies ◽

B. Glisson ◽

V. Papadimitrakopoulou ◽

...

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Hydroxamic Acid ◽

Phase Ii Clinical Trial ◽

Suberoylanilide Hydroxamic Acid

Download Full-text

Economic Analysis of Amifostine as Adjunctive Support for Patients with Advanced Head and Neck Cancer: Preliminary Results from a Randomized Phase II Clinical Trial from Germany

Cancer Investigation ◽

10.1081/cnv-100000145 ◽

2001 ◽

Vol 19 (2) ◽

pp. 107-113 ◽

Author(s):

Charles L. Bennett ◽

David Lane ◽

Tammy Stinson ◽

Michael Glatzel ◽

Jens Buntzel

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Economic Analysis ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Clinical Trial ◽

Advanced Head ◽

Preliminary Results ◽

Randomized Phase Ii

Download Full-text

IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer

Oral Oncology ◽

10.1016/j.oraloncology.2017.03.011 ◽

2017 ◽

Vol 69 ◽

pp. 38-45 ◽

Author(s):

L.P. Stabile ◽

A.M. Egloff ◽

M.K. Gibson ◽

W.E. Gooding ◽

J. Ohr ◽

...

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Clinical Trial

Download Full-text

Faculty Opinions recommendation of Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients with Head and Neck Cancer: Results of the Biology-Driven Phase Ii Clinical Trial Pravacur.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735112423.793557894 ◽

2019 ◽

Author(s):

Wendy Woodward

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Clinical Trial ◽

Radiation Induced

Download Full-text

Phase II clinical trial of suberoylanilide hydroxamic acid (SAHA) in patients (pts) with recurrent and/or metastatic head and neck cancer(SCCHN)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.5578 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5578-5578 ◽

Author(s):

G. Blumenschein ◽

C. Lu ◽

M. Kies ◽

B. Glisson ◽

V. Papadimitrakopoulou ◽

...

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Hydroxamic Acid ◽

Phase Ii Clinical Trial ◽

Suberoylanilide Hydroxamic Acid

Download Full-text

Split-course accelerated hyperfractionated irradiation (CHA-CHA) as a sole treatment for advanced head and neck cancer patients—final results of a randomized clinical trial

British Journal of Radiology ◽

10.1259/bjr.20140212 ◽

2014 ◽

Vol 87 (1041) ◽

pp. 20140212 ◽

Author(s):

L Miszczyk ◽

B Maciejewski ◽

A Tukiendorf ◽

G Woźniak ◽

B Jochymek ◽

...

Keyword(s):

Clinical Trial ◽

Head And Neck Cancer ◽

Head And Neck ◽

Randomized Clinical Trial ◽

Cancer Patients ◽

Neck Cancer ◽

Download Full-text